Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice

Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice

(2010) Jonathan S. Miller et al.   BRAIN RESEARCH BULLETIN

GSK3 signalling in neural development

(2010) Eun-Mi Hur et al.   NATURE REVIEWS NEUROSCIENCE

Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1

(2009) Carine Aubry et al.   BIOORGANIC & MEDICINAL CHEMISTRY

From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer Cells

(2009) Irina N. Gaisina et al.   JOURNAL OF MEDICINAL CHEMISTRY

Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3

(2009) L. Chen et al.   MOLECULAR PHARMACOLOGY

The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3

(2003) Guang Chen et al.   JOURNAL OF NEUROCHEMISTRY